Fennec Pharmaceuticals Inc. is a clinical stage biotechnology company developing Sodium Thiosulfate STS , a chemo protectant against hearing loss associated with platinum based chemotherapy.
Quote | Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Last: | $9.57 |
---|---|
Change Percent: | 1.03% |
Open: | $9.6 |
Close: | $9.57 |
High: | $9.85 |
Low: | $9.46 |
Volume: | 159,643 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
2024-04-11 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-22 12:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Subject | By | Source | When |
---|---|---|---|
We're on fire today! | UFO | investorshub | 09/25/2017 2:23:45 PM |
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | UFO | investorshub | 09/19/2017 11:40:58 AM |
Thanks Renee! U2! $FENC has been | UFO | investorshub | 09/13/2017 1:08:13 PM |
Best o' luck with $FENCF, UFO!! | Renee | investorshub | 09/13/2017 1:03:36 PM |
Wow! Thanks for the news. Wish | UFO | investorshub | 09/13/2017 12:58:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Fennec Pharmaceuticals Inc. Company Name:
FENC Stock Symbol:
NASDAQ Market:
Fennec Pharmaceuticals Inc. Website:
2024-04-11 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-22 12:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...